Showing results (491-500 of 501) with videos related to
Sort By:
Pageof 51
Leukemia|March 10, 2001
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplantsF Keil, E Prinz, P Kalhs, et al.Leukemia|March 23, 1999
Post-transplant acute myeloid leukemia (PT-AML)R Thalhammer-Scherrer, G Wieselthaler, P Knoebl, et al.Journal of Immunological Methods|May 11, 1995
Purification of human basophils and mast cells by multistep separation technique and mAb to CDw17 and CD117/c-kitM Willheim, H Agis, W R Sperr, et al.Leukemia|November 7, 2003
Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcomeI Simonitsch-Klupp, I Hauser, G Ott, et al.Thrombosis Research|September 10, 2014
Lupus anticoagulant and thrombosis in splenic marginal zone lymphomaJ Gebhart, K Lechner, C Skrabs, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cellsW Füreder, H Agis, M Willheim, et al.Leukemia & Lymphoma|August 1, 2002
Serum tryptase measurements in patients with myelodysplastic syndromesW R Sperr, B Stehberger, F Wimazal, et al.Blood|September 25, 2001
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemiaW R Sperr, J H Jordan, M Baghestanian, et al.Annals of Hematology|February 1, 1996
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemiaH T Greinix, F Keil, S A Brugger, et al.Annals of Hematology|June 2, 2000
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemiaH T Greinix, H Loidolt, W Rabitsch, et al.Pageof 51